⌘K

Login Start Free

Home/Filings/4/0001209191-15-049285

4//SEC Filing

RXi Pharmaceuticals Corp 4

Accession 0001209191-15-049285

$PHIOCIK 0001533040operating

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 8:03 AM ET

Size

8.9 KB

Accession

0001209191-15-049285

Insider Transaction Report

Form 4

Period: 2015-06-02

RXi Pharmaceuticals CorpRXII

Director

Transactions

Award
Overallotment purchase right
2015-06-02+18,750→ 18,750 total
Exercise: $0.46From: 2015-06-02Exp: 2016-07-02→ Common stock (18,750 underlying)
Award
Common stock, $0.0001 par value
2015-06-02$0.40/sh+37,500$15,000→ 37,500 total
Award
Common stock warrant
2015-06-02+18,750→ 18,750 total
Exercise: $0.52From: 2015-06-02Exp: 2020-06-02→ Common stock (18,750 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

RXi Pharmaceuticals Corp

CIK 0001533040

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001533040

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 8:03 AM ET
Size: 8.9 KB

View on SEC.gov